Results 31 to 33 of about 299 (33)

Stapokibart (CM310) targets IL-4Rα for the treatment of type 2 inflammation. [PDF]

open access: yesiScience
Liu W   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy